Literature DB >> 3396160

Granulocytes and no-reflow phenomenon in irreversible hemorrhagic shock.

J Barroso-Aranda1, G W Schmid-Schönbein, B W Zweifach, R L Engler.   

Abstract

Recent evidence shows that circulating granulocytes play an important role in capillary stasis and tissue injury. We investigated two aspects of the problem in a Wiggers hemorrhagic shock model of the rat: the survival rate and the microvascular no-reflow phenomenon. A conventional group of rats with normal blood cells and a neutropenic group of rats pretreated with intraperitoneal antigranulocyte antibody were used to evaluate the effects of granulocytes. Two hemorrhagic shock protocols (HSP) were carried out. In HSP-1, the rats were subjected to 40 mm Hg mean arterial pressure for 3 hours. The conventional group (n = 11) showed a 36% survival rate compared with 100% in the neutropenic group (n = 6). In HSP-2, the hypotension was more severe, 30 mm Hg mean arterial pressure for 7 hours. There were no survivors in the conventional group (n = 8), compared with a 100% survival rate in the neutropenic group (n = 6). The extent, location, and mechanism of the no-reflow phenomenon was investigated by examining histological sections from several organs after infusion of a contrast medium to mark vessels with flow in a control group without shock and in the HSP-2 model 2 hours after blood replacement. The arterioles and venules uniformly contained contrast medium in all three groups; only capillaries showed no-reflow. A significantly higher percentage of no-reflow was observed in the capillaries of the conventional shock group than in the neutropenic shock group. We concluded that the obstruction of capillaries was largely due to trapped granulocytes, suggesting that these leukocytes play a key role in the capillary no-reflow phenomenon and survival from hemorrhagic shock.

Entities:  

Mesh:

Year:  1988        PMID: 3396160     DOI: 10.1161/01.res.63.2.437

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  20 in total

1.  Attenuation of spontaneous pseudopod formation in human neutrophils by pentoxifylline.

Authors:  P M Wong; G W Schmid-Schönbein
Journal:  Cell Biophys       Date:  1991-06

2.  Biomechanics of skeletal muscle capillaries: hemodynamic resistance, endothelial distensibility, and pseudopod formation.

Authors:  J Lee; G W Schmid-Schönbein
Journal:  Ann Biomed Eng       Date:  1995 May-Jun       Impact factor: 3.934

3.  Induced hypothermia during resuscitation from hemorrhagic shock attenuates microvascular inflammation in the rat mesenteric microcirculation.

Authors:  Garrett N Coyan; Michael Moncure; James H Thomas; John G Wood
Journal:  Shock       Date:  2014-12       Impact factor: 3.454

4.  Inhibition of Rho-kinase attenuates endothelial-leukocyte interaction during ischemia-reperfusion injury.

Authors:  Qing Mei Wang; Timothy J Stalker; Yulan Gong; Yoshiyuki Rikitake; Rosario Scalia; James K Liao
Journal:  Vasc Med       Date:  2012-09-26       Impact factor: 3.239

Review 5.  Purine metabolism in the heart. Strategies for protection against myocardial ischaemia.

Authors:  K Ver Donck
Journal:  Pharm World Sci       Date:  1994-04-15

6.  [Reperfusion shock after occlusion of the superior mesenteric artery and accumulation of leukocytes within the wall of the small intestine].

Authors:  J Jonas; A Heimann; A Alebrahim-Dehkordy; O Kempski
Journal:  Langenbecks Arch Chir       Date:  1996

7.  Biomechanical aspects of the auto-digestion theory.

Authors:  Geert W Schmid-Schönbein
Journal:  Mol Cell Biomech       Date:  2008-06

Review 8.  [Microcirculation of intensive care patients. From the physiology to the bedside].

Authors:  H Knotzer; W Hasibeder
Journal:  Anaesthesist       Date:  2008-02       Impact factor: 1.041

9.  The protective effect of FK506 pretreatment against renal ischemia/reperfusion injury in rats.

Authors:  M Sakr; G Zetti; C McClain; J Gavaler; M Nalesnik; S Todo; T Starzl; D Van Thiel
Journal:  Transplantation       Date:  1992-05       Impact factor: 4.939

Review 10.  Proclivity of activated neutrophils to cause postischemic cardiac dysfunction: participation in stunning?

Authors:  K Mullane; R Engler
Journal:  Cardiovasc Drugs Ther       Date:  1991-10       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.